Mobile Medical App Makers Should Follow GMPs, Guidance Says

The GMP Letter
Manufacturers of mobile medical applications (apps) that may be devices should follow the quality systems regulations, including current good manufacturing practices, when designing and developing these products, an FDA draft guidance says.

To View This Article:


Subscribe To The GMP Letter

Buy This Article Now

Add this article to your cart for $40.00